Tuesday, 5 October 2021

J&J Takes Lead in RSV Vaccine Race with 80% Efficacy in Phase II

J&J Takes Lead in RSV Vaccine Race with 80% Efficacy in Phase II submitted by /u/shallah
[link] [comments]


from Health https://ift.tt/2WDPQfM
via IFTTT
Posted by at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)